Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PAI-1' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 752 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Herrington, DM; Klein, KP
      Genome and hormones: Gender differences in physiology - Invited review: Pharmacogenetics of estrogen replacement therapy

      JOURNAL OF APPLIED PHYSIOLOGY
    2. Muehlenweg, B; Sperl, S; Magdolen, V; Schmitt, M; Harbeck, N
      Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours

      EXPERT OPINION ON BIOLOGICAL THERAPY
    3. Lutz, V; Reuning, U; Kruger, A; Luther, T; von Steinburg, SP; Graeff, H; Schmitt, M; Wilhelm, OG; Magdolen, V
      High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nudemice

      BIOLOGICAL CHEMISTRY
    4. Harbeck, N; Alt, U; Berger, U; Kruger, A; Thomssen, C; Janicke, F; Hofler, H; Kates, RE; Schmitt, M
      Prognostic impact of proteolytic factors (Urokinase-Type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy

      CLINICAL CANCER RESEARCH
    5. Lin, VCL; Eng, AS; Hen, NE; Ng, EHL; Chowdhury, SH
      Effect of progesterone on the invasive properties and tumor growth of progesterone receptor-transfected breast cancer cells MDA-MB-231

      CLINICAL CANCER RESEARCH
    6. Konecny, G; Untch, M; Pihan, A; Kimmig, R; Gropp, M; Stieber, P; Hepp, H; Slamon, D; Pegram, M
      Association of urokinase-type plasminogen activator and its inhibitor withdisease progression and prognosis in ovarian cancer

      CLINICAL CANCER RESEARCH
    7. Sadowski, T; Steinmeyer, J
      Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1

      INFLAMMATION RESEARCH
    8. Bang, CO; Park, HK; Ahn, MY; Shin, HK; Hwang, KY; Hong, SY
      4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene inatherothrombotic stroke

      CEREBROVASCULAR DISEASES
    9. Fink, T; Ebbesen, P; Zachar, V
      Quantitative gene expression profiles of human liver-derived cell lines exposed to moderate hypoxia

      CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
    10. Fan, JG; Chen, LH; Xu, ZJ; Zeng, MD
      Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver

      WORLD JOURNAL OF GASTROENTEROLOGY
    11. Folkes, A; Roe, MB; Sohal, S; Golec, J; Faint, R; Brooks, T; Charlton, P
      Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    12. Fredstorp-Lidebring, M; Bendahl, PO; Brunner, N; Casslen, B; Hogberg, T; Langstrom-Einarsson, E; Willen, R; Ferno, M
      Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

      EUROPEAN JOURNAL OF CANCER
    13. Kurtzman, AL; Govindarajan, S; Vahle, K; Jones, JT; Heinrichs, V; Patten, PA
      Advances in directed protein evolution by recursive genetic recombination:applications to therapeutic proteins

      CURRENT OPINION IN BIOTECHNOLOGY
    14. Olivotti, L; Spallarossa, P; Piana, A; Iannone, A; Rossettin, P; Ghigliotti, G; Armani, U; Barsotti, A; Brunelli, C
      Maximal endothelial tissue plasminogen activator release is not impaired in patients with acute coronary syndromes before heparin treatment

      BLOOD COAGULATION & FIBRINOLYSIS
    15. Sprouse, JT; Wong, CS; Chandler, WL; Williams, GD; Watkins, SL; Tarr, PI
      Thrombogenic alleles, Escherichia coli O157 : H7 infections, and hemolyticuremic syndrome

      BLOOD COAGULATION & FIBRINOLYSIS
    16. Sulikowski, T; Patston, PA
      The inhibition of TNK-t-PA by C1-inhibitor

      BLOOD COAGULATION & FIBRINOLYSIS
    17. Silveira, A
      Postprandial triglycerides and blood coagulation

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    18. Lottermoser, K; Dusing, R; Ervens, P; Koch, B; Bruning, T; Sachinidis, A; Vetter, H; Ko, Y
      The plasminogen activator inhibitor 1 4G/5G polymorphism is not associatedwith longevity: a study in octogenarians

      JOURNAL OF MOLECULAR MEDICINE-JMM
    19. Benes, P; Muzik, J; Benedik, J; Elbl, L; Vasku, A; Siskova, L; Znojil, V; Vacha, J
      The C766T low-density lipoprotein receptor related protein polymorphism and coronary artery disease, plasma lipoproteins, and longevity in the Czech population

      JOURNAL OF MOLECULAR MEDICINE-JMM
    20. Okopien, B; Cwalina, L; Lebek, M; Kowalski, J; Zielinski, M; Wisniewska-Wanat, M; Kalina, Z; Herman, ZS
      Effects of fibrates on plasma prothrombotic activity in patients with TypeIIb dyslipidemia

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    21. Pandolfi, A; Giaccari, A; Cilli, C; Alberta, MM; Morviducci, L; De Filippis, EA; Buongiorno, A; Pellegrini, G; Capani, F; Consoli, A
      Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat

      ACTA DIABETOLOGICA
    22. Huber, K
      Plasminogen activator inhibitor type-1 (part one): Basic mechanisms, regulation, and role for thromboembolic disease

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    23. Huber, K
      Plasminogen activator inhibitor type-1 (part two): Role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    24. Choi-Miura, NH
      SP-40,40 is a component of plasminogen activator inhibitor-1-binding protein and stabilizes plasminogen activator inhibitor-1 activity

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    25. Epstein, M
      Aldosterone as a mediator of progressive renal dysfunction: Evolving perspectives

      INTERNAL MEDICINE
    26. Konno, H; Abe, J; Kaneko, T; Baba, M; Shoji, A; Sunayama, K; Kamiya, K; Tanaka, T; Suzuki, S; Nakamura, S; Urano, T
      Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer

      JAPANESE JOURNAL OF CANCER RESEARCH
    27. Nowak-Gottl, U; Strater, R; Kosch, A; von Eckardstein, A; Schobess, R; Luigs, P; Nabel, P; Vielhaber, H; Kurnik, K; Junker, R
      The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is notassociated with ischemic stroke in a population of German children

      EUROPEAN JOURNAL OF HAEMATOLOGY
    28. Mandl-Weber, S; Haslinger, B; Schalkwijk, CG; Sitter, T
      Early glycated albumin, but not advanced glycated albumin, methylglyoxal, or 3-deoxyglucosone increases the expression of PAI-1 in human peritoneal mesothelial cells

      PERITONEAL DIALYSIS INTERNATIONAL
    29. Kario, K; Matsuo, T; Kobayashi, H; Hoshide, S; Shimada, K
      Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    30. Chappuis, PO; Dieterich, B; Sciretta, V; Lohse, C; Bonnefoi, H; Remadi, S; Sappino, AP
      Functional evaluation of plasmin formation in primary breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    31. Underwood, PA; Bean, PA; Cubeddu, L
      Human endothelial cells grow poorly on vitronectin: Role of PAI-1

      JOURNAL OF CELLULAR BIOCHEMISTRY
    32. Bonfigli, AR; Pieri, C; Manfrini, S; Testa, I; Sirolla, C; Ricciotti, R; Marra, M; Compagnucci, P; Testa, R
      Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients

      DIABETES NUTRITION & METABOLISM
    33. Thomas, CMG; Sweep, CGJ
      Serum tumor markers: past, state of the art, and future

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    34. Taponeco, F; Curcio, C; Giuntini, A; Nardini, V; Fornaciari, G; Artini, PG; D'Ambrogio, G; Genazzini, AR
      Expression and prognostic significance of urokinase and plasminogen activator inhibitor type-1 in endometrial hyperplasia and cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    35. Smolarz, B; Blasiak, J; Kulig, A; Romanowicz-Makowska, H; Dziki, A; Ulanska, J; Pander, B; Szewczyk, T
      Plasminogen activator inhibitor 1 (PAI-1) levels and gene promoter polymorphisms in subjects with colorectal cancer

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    36. Martina, V; Bruno, GA; Zumpano, E; Origlia, C; Quaranta, L; Pescarmona, GP
      Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    37. Forastiero, R; Martinuzzo, M; Adamczuk, Y; Varela, MLI; Pombo, G; Carreras, LO
      The combination of thrombophilic genotypes is associated with definite antiphospholipid syndrome

      HAEMATOLOGICA
    38. Harbeck, N; Kruger, A; Sinz, S; Kates, RE; Thomssen, C; Schmitt, M; Janicke, F
      Clinical relevance of the plasminogen activator inhibitor type 1 - a multifaceted proteolytic factor

      ONKOLOGIE
    39. Sartori, MT; Vettor, R; De Pergola, G; De Mitrio, V; Saggiorato, G; Della Mea, P; Patrassi, GM; Lombardi, AM; Fabris, R; Girolami, A
      Role of the 4G/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients - Influence of fat distribution and insulin-resistance

      THROMBOSIS AND HAEMOSTASIS
    40. Zareba, W; Pancio, G; Moss, AJ; Kalaria, VG; Marder, VJ; Weiss, HJ; Watelet, LFM; Sparks, CE
      Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients

      THROMBOSIS AND HAEMOSTASIS
    41. Raaphorst, J; Groeneveld, ABJ; Bossink, AWJ; Hack, CE
      Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients

      THROMBOSIS AND HAEMOSTASIS
    42. Christ, G; Graf, S; Huber-Beckmann, R; Zorn, G; Lang, I; Kneussl, M; Binder, BR; Huber, K
      Impairment of the plasmin activation system in primary pulmonary hypertension: Evidence for gender differences

      THROMBOSIS AND HAEMOSTASIS
    43. Estelles, A; Dalmou, J; Falco, C; Berbel, O; Castello, R; Espana, F; Aznar, J
      Plasma PAI-1 levels in obese children - Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype

      THROMBOSIS AND HAEMOSTASIS
    44. Bertina, RM
      Genetic approach to thrombophilia

      THROMBOSIS AND HAEMOSTASIS
    45. Morange, PE; Renucci, JF; Charles, MA; Aillaud, MF; Giraud, F; Grimaux, M; Juhan-Vague, I
      Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers

      THROMBOSIS AND HAEMOSTASIS
    46. Pawlowska, Z; Chabielska, E; Kobylanska, A; Maciaszek, A; Swiatkowska, M; Buczko, W; Stec, WJ; Cierniewski, CS
      Regulation of PAI-1 concentration in platelets by systemic administration of antisense oligonucleotides to rats

      THROMBOSIS AND HAEMOSTASIS
    47. Bijnens, AP; Ngo, TH; Gils, A; Dewaele, J; Knockaert, I; Stassen, JM; Declerck, PJ
      Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1

      THROMBOSIS AND HAEMOSTASIS
    48. Reiner, AP; Siscovick, DS; Rosendaal, FR
      Hemostatic risk factors and arterial thrombotic disease

      THROMBOSIS AND HAEMOSTASIS
    49. Kroon, ME; Koolwijk, P; Vermeer, MA; van der Vecht, B; van Hinsbergh, VWM
      Vascular endothelial growth factor enhances the expression of urokinase receptor in human endothelial cells via protein kinase C activation

      THROMBOSIS AND HAEMOSTASIS
    50. Sudi, KM; Gallistl, S; Trobinger, M; Payerl, D; Weinhandl, G; Muntean, W; Aigner, R; Borkenstein, MH
      The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents

      JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
    51. Rissanen, P; Vahtera, E; Krusius, T; Uusitupa, M; Rissanen, A
      Weight change and blood coagulability and fibrinolysis in healthy obese women

      INTERNATIONAL JOURNAL OF OBESITY
    52. Aoki, K; Aikawa, N; Sekine, K; Yamazaki, M; Mimura, T; Urano, T; Takada, A
      Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns

      BURNS
    53. Mandl-Weber, S; Haslinger, B; Lederer, SR; Sitter, T
      Heat-killed microorganisms induce PAI-1 expression in human peritoneal mesothelial cells: Role of interleukin-1 alpha

      AMERICAN JOURNAL OF KIDNEY DISEASES
    54. Epstein, M
      Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift

      JOURNAL OF HYPERTENSION
    55. Brooks, TD; Slomp, J; Quax, PHA; De Bart, ACW; Spencer, MT; Verheijen, JH; Charlton, PA
      Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro

      CLINICAL & EXPERIMENTAL METASTASIS
    56. Rerolle, JP; Vigneau, C; Hertig, A; Berrou, J; Rondeau, E
      Plasminogen activator inhibitor type 1: physiology and role in renal pathophysiology

      NEPHROLOGIE
    57. Morgenstern, E; Gnad, U; Preissner, KT; Dierichs, R; Belleli, A; Chestukhin, A; Schvartz, I; Shaltiel, S
      Localization of protein kinase A and vitronectin in resting platelets and their translocation onto fibrin fibers during clot formation

      EUROPEAN JOURNAL OF CELL BIOLOGY
    58. He, C; He, P; Liu, LP; Zhu, YS
      Analysis of expressions of components in the plasminogen activator system in high- and low-metastatic human lung cancer cells

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    59. Ortlepp, JR; Hoffmann, R; Killian, A; Lauscher, J; Merkelbach-Bruse, S; Hanrath, P
      The 4G/5G promotor polymorphism of the plasminogen activator inhibitor-1 gene and late lumen loss after coronary stent placement in smoking and nonsmoking patients

      CLINICAL CARDIOLOGY
    60. Lopez, S; Peiretti, F; Bonardo, B; Deprez-Beauclair, P; Laouenan, H; Juhan-Vague, I; Nalbone, G
      Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesisin human monocytes/macrophages

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    61. Hanley, AJG; McKeown-Eyssen, G; Harris, SB; Hegele, RA; Wolever, TMS; Kwan, J; Connelly, PW; Zinman, B
      Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition

      DIABETES CARE
    62. Huang, YH; Liu, CC; Wang, ST; Lei, HY; Liu, HS; Lin, YS; Wu, HL; Yeh, TM
      Activation of coagulation and fibrinolysis during dengue virus infection

      JOURNAL OF MEDICAL VIROLOGY
    63. Tabengwa, EM; Grenett, HE; Benza, RL; Abou-Agag, LH; Tresnak, JK; Wheeler, CG; Booyse, FM
      Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    64. de Lange, M; Snieder, H; Ariens, RAS; Spector, TD; Grant, PJ
      The genetics of haemostasis: a twin study

      LANCET
    65. Cho, SH; Hall, IP; Wheatley, A; Dewar, J; Abraha, D; Del Mundo, J; Lee, H; Oh, CK
      Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor I gene in the development of asthma

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    66. Tecimer, C; Doering, DL; Goldsmith, LJ; Meyer, JS; Abdulhay, G; Wittliff, JL
      Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer

      GYNECOLOGIC ONCOLOGY
    67. Wang, AYM; Poon, P; Lai, FM; Yu, LM; Choi, PCL; Lui, SF; Li, PKT
      Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients

      KIDNEY INTERNATIONAL
    68. Noguchi, T; Matsuyama, S; Akao, M; Hagiwara, H; Uno, S; Seki, T; Ariga, T
      Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats

      THROMBOSIS RESEARCH
    69. Prisco, D; Fedi, S; Antonucci, E; Capanni, M; Chiarugi, L; Chioccioli, M; Falai, M; Giglioli, C; Abbate, R; Gensini, GF
      Postprocedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA

      THROMBOSIS RESEARCH
    70. Nowak-Gottl, U; Kotthoff, S; Hagemeyer, E; Junker, R; Kehl, HG; Vielhaber, H; Kececioglu, D
      Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease - A prospective study

      THROMBOSIS RESEARCH
    71. Huber, K; Christ, G; Wojta, J; Gulba, D
      Plasminogen activator inhibitor type-1 in cardiovascular disease - Status report 2001

      THROMBOSIS RESEARCH
    72. Polac, I; Cierniewska-Cieslak, A; Stachowiak, G; Pertynski, T; Cierniewski, CS
      Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women

      THROMBOSIS RESEARCH
    73. Vambergue, A; Rugeri, L; Gaveriaux, V; Devos, P; Martin, A; Fermon, C; Fontaine, P; Jude, B
      Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor indiabetes mellitus: Influence of type of diabetes, obesity index, and age

      THROMBOSIS RESEARCH
    74. Espinosa, G; Tassies, D; Font, J; Munoz-Rodriguez, FJ; Cervera, R; Ordinas, A; Reverter, JC; Ingelmo, M
      Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis

      SEMINARS IN ARTHRITIS AND RHEUMATISM
    75. Nielsen, HJ; Mortensen, T; Holten-Andersen, M; Brunner, N; Sorensen, S; Rask-Madsen, J
      Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohndisease

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    76. Tjarnstrom, J; Holmdahl, L; Falk, P; Falkenberg, M; Arnell, P; Risberg, B
      Effects of hyperbaric oxygen on expression of fibrinolytic factors of human endothelium in a simulated ischaemia/reperfusion situation

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    77. Glueck, CJ; Kupferminc, MJ; Fontaine, RN; Wang, P; Weksler, BB; Eldor, A
      Genetic hypofibrinolysis in complicated pregnancies

      OBSTETRICS AND GYNECOLOGY
    78. Mutch, NJ; Wilson, HM; Booth, NA
      Plasminogen activator inhibitor-1 and haemostasis in obesity

      PROCEEDINGS OF THE NUTRITION SOCIETY
    79. Sudi, K; Gallistl, S; Payerl, D; Aigner, R; Moller, R; Tafeit, E; Borkenstein, MH
      Interrelationship between estimates of adiposity and body fat distributionwith metabolic and hemostatic parameters in obese children

      METABOLISM-CLINICAL AND EXPERIMENTAL
    80. Briones, A; Nauffal, D; Villa, P; Martinez, MA; Menendez, R; Perpina, M
      Clinical manifestations and prevalence of hypercoagulable states in patients with venous thromboembolic disease

      MEDICINA CLINICA
    81. Suzuki, Y; Urano, T; Ihara, H; Nakajima, T; Nagai, N; Takada, Y; Taminato, T; Takada, A
      Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger RNA by a combination of mono-unsaturated fatty acid and insulin in HepG2 cells

      LIFE SCIENCES
    82. Stoop, AA; Eldering, E; Dafforn, TR; Read, RJ; Pannekoek, H
      Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries

      JOURNAL OF MOLECULAR BIOLOGY
    83. Chung, HW; Wen, Y; Ahn, JJ; Moon, HS; Polan, ML
      Interleukin-1 beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    84. Deng, G; Curriden, SA; Hu, G; Czekay, RP; Loskutoff, DJ
      Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin

      JOURNAL OF CELLULAR PHYSIOLOGY
    85. Seki, T; Miyasu, T; Noguchi, T; Hamasaki, A; Sasaki, R; Ozawa, Y; Okukita, K; Declerck, PJ; Ariga, T
      Reciprocal regulation of tissue-type and urokinase-type plasminogen activators in the differentiation of murine preadipocyte line 3T3-L1 and the hormonal regulation of fibrinolytic factors in the mature adipocytes

      JOURNAL OF CELLULAR PHYSIOLOGY
    86. Kutz, SM; Hordines, J; McKeown-Longo, PJ; Higgins, PJ
      TGF-beta 1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion

      JOURNAL OF CELL SCIENCE
    87. Boncela, J; Papiewska, I; Fijalkowska, I; Walkowiak, B; Cierniewski, CS
      Acute phase protein alpha(1)-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    88. Ngo, TH; Hoylaerts, MF; Knockaert, I; Brouwers, E; Declerck, PJ
      Identification of a target site in plasminogen activator inhibitor-1 that allows neutralization of its inhibitory properties concomitant with an allosteric up-regulation of its antiadhesive properties

      JOURNAL OF BIOLOGICAL CHEMISTRY
    89. Urano, T; Ihara, H; Umemura, K; Suzuki, Y; Oike, M; Akita, S; Tsukamoto, Y; Suzuki, I; Takada, A
      The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    90. Lee, SH; Cho, YS; Shim, CS; Kim, JS; Choi, JJ; Oh, SH; Kim, JW; Zhang, W; Lee, JH
      Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervicalcarcinoma cell line

      INTERNATIONAL JOURNAL OF CANCER
    91. Glueck, CJ; Phillips, H; Cameron, D; Sieve-Smith, L; Wang, P
      Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

      FERTILITY AND STERILITY
    92. Wind, T; Jensen, MA; Andreasen, PA
      Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1 - Implications for antibody-mediated PAI-1-neutralization and vitronectin-binding

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    93. Egelund, R; Petersen, TE; Andreasen, PA
      A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    94. Koziczak, M; Muller, H; Helin, K; Nagamine, Y
      E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    95. Nordt, TK; Bode, C; Sobel, BE
      Stimulation in vivo of expression of intra-abdominal adipose tissue plasminogen activator inhibitor Type I by proinsulin

      DIABETOLOGIA
    96. Mavri, A; Alessi, MC; Bastelica, D; Geel-Georgelin, O; Fina, F; Sentocnik, JT; Stegnar, M; Juhan-Vague, I
      Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

      DIABETOLOGIA
    97. Duffy, MJ
      Biochemical markers in breast cancer: which ones are clinically useful?

      CLINICAL BIOCHEMISTRY
    98. DeYoung, MB; Tom, C; Dichek, DA
      Plasminogen activator inhibitor type I increases neointima formation in balloon-injured rat carotid arteries

      CIRCULATION
    99. Konstantinides, S; Schafer, K; Thinnes, T; Loskutoff, DJ
      Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice

      CIRCULATION
    100. Venugopal, B; Sharon, R; Abramovitz, R; Khasin, A; Miskin, R
      Plasminogen activator inhibitor-1 in cardiovascular cells: rapid inductionafter injecting mice with kainate or adrenergic agents

      CARDIOVASCULAR RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 19:08:45